Fig. 4. Outcome from HSCT comparing GATA2mut and GATA2wt patients.
Disease-free survival in GATA2mut vs GATA2wt cohorts for patients A with RCC and normal karyotype, B RCC and monosomy 7, C MDS-EB and monosomy 7 and D MDS-EBt/AML and monosomy 7. RCC refractory cytopenia of childhood, MDS-EB MDS with excess blasts, MDS-EBt MDS with excess blasts in transformation, AML MDS-related acute myeloid leukemia, N numbers in subgroup, E events.